December 2025
1. HUA K, Jin J, Zhao J, Song J, et al
   [Expression of Concern] miR?135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
   Int J Oncol. 2025;67:96.
   

   >> Share

   
   
2. GELSOMINO L, Del Console P, Murfuni MS, Gaspari M, et al
   Adipocyte?derived extracellular vesicles sustain mitochondrial metabolism in breast cancer cells: New insights into the cross?talk between cancer cells and the tumor microenvironment.
   Int J Oncol. 2025;67:100.
   

   >> Share

   
   
3. JIN ML, Park SY, Kim YH, Park G, et al
   [Expression of Concern] Halofuginone induces the apoptosis of breast cancer cells and inhibits migration via downregulation of matrix metalloproteinase?9.
   Int J Oncol. 2025;67:106.
   

   >> Share

   
   November 2025
4. ZOU X, Li S, Huang S, Niu R, et al
   Harnessing TP73?targeted nintedanib: A novel strategy to halt triple?negative breast cancer via p53?PPARalpha/PI3K?Akt pathway suppression.
   Int J Oncol. 2025;67:88.
   

   >> Share

   
   
5. HUANG X, Luo W, Liu W, Liu X, et al
   Progerin regulates actin cytoskeletal remodeling and inhibits EMT and metastasis in triple?negative breast cancer cells.
   Int J Oncol. 2025;67:92.
   

   >> Share

   
   August 2025
6. KAUSAR MA, Alshammari KF, Alenazi F, Anwar S, et al
   RAD51 and PALB2 in precision oncology: Clinical implications for HRD associated breast and ovarian cancers (Review).
   Int J Oncol. 2025;67:65.
   

   >> Share

   
   
7. CHUNG SS, Giehl N, Wu Y, Vadgama JV, et al
   [Corrigendum] STAT3 activation in HER2?overexpressing breast cancer promotes epithelial?mesenchymal transition and cancer stem cell traits.
   Int J Oncol. 2025;67:69.
   

   >> Share

   
   July 2025
8. PARK AY, Kim JH, Lee S, Kim HS, et al
   Impact of PD?L1 upregulation on immune checkpoint inhibitor efficacy in triple?negative breast cancer using a 4T1 murine model.
   Int J Oncol. 2025;67:54.
   

   >> Share

   
   June 2025
9. ZHANG X, Zhao X, Shao S, Zuo X, et al
   [Retracted] Notch1 induces epithelial?mesenchymal transition and the cancer stem cell phenotype in breast cancer cells and STAT3 plays a key role.
   Int J Oncol. 2025;66:46.
   

   >> Share

   
   
10. KIM ES
    Molecular targets and therapies associated with poor prognosis of triple?negative breast cancer (Review).
    Int J Oncol. 2025;66:52.
    

    >> Share

    
    May 2025
11. SUN MX, Zhu HC, Yu Y, Yao Y, et al
    Role of the Wnt signaling pathway in the complex microenvironment of breast cancer and prospects for therapeutic potential (Review).
    Int J Oncol. 2025;66:36.
    

    >> Share

    
    
12. GIL EY, Jo UH, Jeong H, Whang YM, et al
    [Retracted] Promoter methylation of RASSF1A modulates the effect of the microtubule?targeting agent docetaxel in breast cancer.
    Int J Oncol. 2025;66:39.
    

    >> Share

    
    January 2025
13. LEE WX, Yeo BS, Mahmud R, Tan GC, et al
    MicroRNAs and their role in breast cancer metabolism (Review).
    Int J Oncol. 2025;66:7.
    

    >> Share

    
    October 2024
14. SOLEK J, Braun M, Sadej R, Romanska HM, et al
    FGFR?related phenotypic and functional profile of CAFs in prognostication of breast cancer (Review).
    Int J Oncol. 2024;65:94.
    

    >> Share

    
    September 2024
15. YANG Y, Gao F, Ren L, Ren N, et al
    Functions and mechanisms of RNA m(6)A regulators in breast cancer (Review).
    Int J Oncol. 2024;65:86.
    

    >> Share

    
    
16. FU Z, Song P, Li D, Yi C, et al
    [Corrigendum] Cancer?associated fibroblasts from invasive breast cancer have an attenuated capacity to secrete collagens.
    Int J Oncol. 2024;65:87.
    

    >> Share

    
    May 2024
17. AI L, Yi N, Qiu C, Huang W, et al
    Revolutionizing breast cancer treatment: Harnessing the related mechanisms and drugs for regulated cell death (Review).
    Int J Oncol. 2024;64:46.
    

    >> Share

    
    April 2024
18. MBUGUA RW, Takano A, Tsevegjav B, Yokose T, et al
    Characterization of KIF20B as a novel prognostic biomarker and therapeutic target for breast cancer.
    Int J Oncol. 2024;64:43.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share